Skip to main content
Top
Published in: Critical Care 3/2011

Open Access 01-06-2011 | Research

Association between IL-32 genotypes and outcome in infection-associated acute lung injury

Authors: John J Arcaroli, Nianjun Liu, Nengjun Yi, Edward Abraham

Published in: Critical Care | Issue 3/2011

Login to get access

Abstract

Introduction

Our purpose was to investigate variation within the IL-32 promoter and gene, and susceptibility to and outcomes from infection associated acute lung injury (ALI).

Methods

Retrospective case-control study involving healthy individuals (controls) and patients (cases) with infection-associated ALI. Two hundred fifty-eight healthy normal controls and 251 patients with infection-associated ALI were used for comparison. The IL-32 promoter/gene was sequenced in 52 healthy Caucasian individuals to identify single nucleotide polymorphisms (SNPs). Allelic discrimination was performed on 11 SNPs to determine differences between cases and controls and outcomes in patients with infection associated ALI.

Results

Logistic and normal regression models were used to evaluate the associations with SNPs in cases and controls, and outcomes in patients with infection associated ALI. rs12934561, an intronic SNP, was found to be associated with risk for ALI in the case-control study and with more severe clinical course, as shown by increased time on the ventilator and the presence of fluid unresponsive hypotension. Further, it was found that rs12934561 has gender-specific effects and strongly interacts with other SNPs.

Conclusions

A common IL-32 genotype, rs12934561, is associated with the risk of ALI as well as the need for prolonged mechanical ventilatory support. This finding suggests that IL-32 is not only involved in the initiating inflammatory and cellular events that result in ALI, but also participates in determining the severity of pulmonary dysfunction associated with ALI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994, 271: 226-233. 10.1001/jama.271.3.226CrossRefPubMed Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994, 271: 226-233. 10.1001/jama.271.3.226CrossRefPubMed
2.
3.
go back to reference Abraham E, Kaneko DJ, Shenkar R: Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999, 276: L1-8.PubMed Abraham E, Kaneko DJ, Shenkar R: Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999, 276: L1-8.PubMed
4.
go back to reference Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996, 157: 1630-1637.PubMed Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996, 157: 1630-1637.PubMed
5.
go back to reference Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995, 16: 21-26. 10.1016/0167-5699(95)80066-2CrossRefPubMed Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995, 16: 21-26. 10.1016/0167-5699(95)80066-2CrossRefPubMed
6.
go back to reference Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P: Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med 1994, 123: 394-399.PubMed Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P: Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med 1994, 123: 394-399.PubMed
7.
go back to reference Gatti S, Faggioni R, Echtenacher B, Ghezzi P: Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 1993, 91: 456-461.PubMedCentralCrossRefPubMed Gatti S, Faggioni R, Echtenacher B, Ghezzi P: Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 1993, 91: 456-461.PubMedCentralCrossRefPubMed
8.
go back to reference Parsey MV, Tuder RM, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 1998, 160: 1007-1013.PubMed Parsey MV, Tuder RM, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 1998, 160: 1007-1013.PubMed
9.
go back to reference Matthay MA, Zimmerman GA: Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005, 33: 319-327. 10.1165/rcmb.F305PubMedCentralCrossRefPubMed Matthay MA, Zimmerman GA: Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005, 33: 319-327. 10.1165/rcmb.F305PubMedCentralCrossRefPubMed
10.
go back to reference Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22: 131-142.PubMed Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22: 131-142.PubMed
11.
go back to reference Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102: 16309-16314. 10.1073/pnas.0508237102PubMedCentralCrossRefPubMed Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102: 16309-16314. 10.1073/pnas.0508237102PubMedCentralCrossRefPubMed
12.
go back to reference Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA: IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 2009, 106: 3883-3888. 10.1073/pnas.0813334106PubMedCentralCrossRefPubMed Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA: IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 2009, 106: 3883-3888. 10.1073/pnas.0813334106PubMedCentralCrossRefPubMed
13.
go back to reference Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello C, Saetta M: IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178: 894-901. 10.1164/rccm.200804-646OCCrossRefPubMed Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello C, Saetta M: IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178: 894-901. 10.1164/rccm.200804-646OCCrossRefPubMed
14.
go back to reference Sorrentino C, Di Carlo E: Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 2009, 180: 769-779. 10.1164/rccm.200903-0400OCCrossRefPubMed Sorrentino C, Di Carlo E: Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 2009, 180: 769-779. 10.1164/rccm.200903-0400OCCrossRefPubMed
15.
go back to reference Seo EH, Kang J, Kim KH, Cho MC, Lee S, Kim HJ, Kim JH, Kim EJ, Park DK, Kim SH, Choi YK, Kim JM, Hong JT, Yoon DY, Eun-Hee S, Kang J, Ki KH: Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 2008, 18: 1606-1612.PubMed Seo EH, Kang J, Kim KH, Cho MC, Lee S, Kim HJ, Kim JH, Kim EJ, Park DK, Kim SH, Choi YK, Kim JM, Hong JT, Yoon DY, Eun-Hee S, Kang J, Ki KH: Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 2008, 18: 1606-1612.PubMed
16.
go back to reference Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007, 149: 480-486. 10.1111/j.1365-2249.2007.03439.xPubMedCentralCrossRefPubMed Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007, 149: 480-486. 10.1111/j.1365-2249.2007.03439.xPubMedCentralCrossRefPubMed
17.
go back to reference Shoda H, Fujio K, Yamamoto K: Rheumatoid arthritis and interleukin-32. Cell Mol Life Sci 2007, 64: 2671-2679. 10.1007/s00018-007-7186-8CrossRefPubMed Shoda H, Fujio K, Yamamoto K: Rheumatoid arthritis and interleukin-32. Cell Mol Life Sci 2007, 64: 2671-2679. 10.1007/s00018-007-7186-8CrossRefPubMed
18.
go back to reference Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB: IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103: 3298-3303. 10.1073/pnas.0511233103PubMedCentralCrossRefPubMed Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB: IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103: 3298-3303. 10.1073/pnas.0511233103PubMedCentralCrossRefPubMed
19.
go back to reference Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G: Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005, 16: 289-292.PubMed Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G: Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005, 16: 289-292.PubMed
20.
go back to reference Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, Kim SJ, Kim SY: Identification of the most active interleukin-32 isoform. Immunology 2009, 126: 535-542. 10.1111/j.1365-2567.2008.02917.xPubMedCentralCrossRefPubMed Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, Kim SJ, Kim SY: Identification of the most active interleukin-32 isoform. Immunology 2009, 126: 535-542. 10.1111/j.1365-2567.2008.02917.xPubMedCentralCrossRefPubMed
21.
go back to reference Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351: 327-336.CrossRefPubMed Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351: 327-336.CrossRefPubMed
22.
go back to reference Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 2002, 11: 2463-2468. 10.1093/hmg/11.20.2463CrossRefPubMed Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 2002, 11: 2463-2468. 10.1093/hmg/11.20.2463CrossRefPubMed
24.
go back to reference Balding DJ: A tutorial on statistical methods for population association studies. Nat Rev Genet 2006, 7: 781-791. 10.1038/nrg1916CrossRefPubMed Balding DJ: A tutorial on statistical methods for population association studies. Nat Rev Genet 2006, 7: 781-791. 10.1038/nrg1916CrossRefPubMed
25.
go back to reference Yi N, Banerjee S: Hierarchical generalized linear models for multiple quantitative trait locus mapping. Genetics 2009, 181: 1101-1113. 10.1534/genetics.108.099556PubMedCentralCrossRefPubMed Yi N, Banerjee S: Hierarchical generalized linear models for multiple quantitative trait locus mapping. Genetics 2009, 181: 1101-1113. 10.1534/genetics.108.099556PubMedCentralCrossRefPubMed
26.
go back to reference Yi N, Kaklamani VG, Pasche B: Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk. Ann Hum Genet 2011, 75: 90-104. 10.1111/j.1469-1809.2010.00605.xPubMedCentralCrossRefPubMed Yi N, Kaklamani VG, Pasche B: Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk. Ann Hum Genet 2011, 75: 90-104. 10.1111/j.1469-1809.2010.00605.xPubMedCentralCrossRefPubMed
27.
go back to reference Gelman A JA, Pittau MG, Su YS: A weakly informative default prior distribution for logistic and other regression models. Annals of Applied Statistics 2008, 2: 1360-1383. 10.1214/08-AOAS191CrossRef Gelman A JA, Pittau MG, Su YS: A weakly informative default prior distribution for logistic and other regression models. Annals of Applied Statistics 2008, 2: 1360-1383. 10.1214/08-AOAS191CrossRef
28.
go back to reference Allen AS, Satten GA: A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease. Genet Epidemiol 2009, 33: 657-667. 10.1002/gepi.20417PubMedCentralCrossRefPubMed Allen AS, Satten GA: A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease. Genet Epidemiol 2009, 33: 657-667. 10.1002/gepi.20417PubMedCentralCrossRefPubMed
29.
go back to reference Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, Azam T, Dinarello CA, Lee S, Her E, Rhof G, Kim S: Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNF[alpha] and IL-1[beta]. Cytokine 2010, 49: 171-176. 10.1016/j.cyto.2009.10.003CrossRefPubMed Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, Azam T, Dinarello CA, Lee S, Her E, Rhof G, Kim S: Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNF[alpha] and IL-1[beta]. Cytokine 2010, 49: 171-176. 10.1016/j.cyto.2009.10.003CrossRefPubMed
30.
go back to reference Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM: Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2009, 156: 479-487. 10.1111/j.1365-2249.2009.03920.xPubMedCentralCrossRefPubMed Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM: Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2009, 156: 479-487. 10.1111/j.1365-2249.2009.03920.xPubMedCentralCrossRefPubMed
31.
32.
33.
go back to reference Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC: Interleukin-32β propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS ONE 2010, 5: e9458. 10.1371/journal.pone.0009458PubMedCentralCrossRefPubMed Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC: Interleukin-32β propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS ONE 2010, 5: e9458. 10.1371/journal.pone.0009458PubMedCentralCrossRefPubMed
34.
go back to reference Abraham E: Neutrophils and acute lung injury. Crit Care Med 2003, 31: S195-199. 10.1097/01.CCM.0000057843.47705.E8CrossRefPubMed Abraham E: Neutrophils and acute lung injury. Crit Care Med 2003, 31: S195-199. 10.1097/01.CCM.0000057843.47705.E8CrossRefPubMed
35.
go back to reference Wheeler AP, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369: 1553-1564. 10.1016/S0140-6736(07)60604-7CrossRefPubMed Wheeler AP, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369: 1553-1564. 10.1016/S0140-6736(07)60604-7CrossRefPubMed
36.
go back to reference Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000, 342: 1334-1349. 10.1056/NEJM200005043421806CrossRefPubMed Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000, 342: 1334-1349. 10.1056/NEJM200005043421806CrossRefPubMed
37.
go back to reference Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992, 145: 1016-1022.CrossRefPubMed Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992, 145: 1016-1022.CrossRefPubMed
38.
go back to reference Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001, 29: 628-634. 10.1097/00003246-200103000-00029CrossRefPubMed Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001, 29: 628-634. 10.1097/00003246-200103000-00029CrossRefPubMed
39.
go back to reference Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW: Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol 2006, 291: L1267-L1276. 10.1152/ajplung.00097.2006CrossRefPubMed Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW: Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol 2006, 291: L1267-L1276. 10.1152/ajplung.00097.2006CrossRefPubMed
40.
go back to reference O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF: Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 2001, 163: 1591-1598.CrossRefPubMed O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF: Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 2001, 163: 1591-1598.CrossRefPubMed
41.
go back to reference Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA: Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137: 288-296. 10.1378/chest.09-1484PubMedCentralCrossRefPubMed Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA: Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137: 288-296. 10.1378/chest.09-1484PubMedCentralCrossRefPubMed
Metadata
Title
Association between IL-32 genotypes and outcome in infection-associated acute lung injury
Authors
John J Arcaroli
Nianjun Liu
Nengjun Yi
Edward Abraham
Publication date
01-06-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10258

Other articles of this Issue 3/2011

Critical Care 3/2011 Go to the issue